News
April 4, 2006

Accession Issues for Supplementary Protection Certificates

Arnold & Porter Advisory

Patented pharmaceutical products often require extensive testing prior to marketing authorisation approval being granted. As a result, a form of extended protection was introduced by EU Regulation (No. 1768/92) known as 'Supplementary Protection Certificates' ("SPC"). The extension given by an SPC is designed to compensate, to an extent, for the patent life lost in obtaining such marketing authorisation approval.

People

Subscribe
Subscribe Link

Email Disclaimer